Chemplast Sanmar reported a consolidated net loss of ₹119.2 crore in the quarter ended December 2025, marking the fourth consecutive quarter of losses for the company. According to the latest consolidated financial data, this represents a significant deterioration from the previous quarter's performance, with the company experiencing sustained financial challenges. The company's consolidated total income declined 19.2% quarter-on-quarter to ₹840.52 crore from ₹1,040.19 crore in the previous quarter, and 21.33% year-on-year from ₹1,068.36 crore in the corresponding quarter of the previous year. Despite the challenging financial results, recent market data shows the company's stock price has demonstrated resilience with a 16.03% gain over the past week and 28.09% growth over the past month.
The company's consolidated revenue declined 19.2% quarter-on-quarter to ₹840.52 crore, representing the lowest quarterly revenue decline in the last 3 years. As reported in the latest consolidated financial data, this revenue contraction has contributed significantly to the overall financial performance deterioration. The company's sequential revenue decline of 19.2% from the previous quarter's ₹1,040.19 crore reflects the challenging operating environment faced by the company during the December 2025 quarter. However, recent market data indicates a modest increase of 4.07% year-on-year to ₹1,033.20 crores, though it experienced a concerning sequential decline of 6.06% from the previous quarter.
The company's operating profit margin (OPM) turned negative at -2.83% in the December 2025 quarter, compared to a positive 2.49% OPM in the corresponding quarter of the previous year. According to the latest consolidated financial data, this represents a significant shift in operational efficiency, with the company moving from positive to negative margins year-on-year. However, recent operational improvements show the operating margin improved slightly to 4.19%, up from 2.60% a year earlier, though this remains well below industry standards. The company's interest expenses of ₹60.33 crores have overshadowed operational improvements, with interest costs alone exceeding operating profit, leading to a pre-tax loss of ₹62.19 crores.
PBDT (Profit Before Depreciation and Tax) declined 1469% to -₹37.66 crore in the December 2025 quarter from -₹2.40 crore in the previous year quarter. The PBT (Profit Before Tax) fell 105% to -₹76.73 crore compared to -₹37.39 crore in the corresponding quarter of the previous year. As reported in the latest consolidated financial data, these profitability metrics reflect the challenging operating environment faced by the company during the quarter. The company's interest expenses of ₹60.33 crores have overshadowed operational improvements, with interest costs alone exceeding operating profit, leading to a pre-tax loss of ₹62.19 crores. The company has also spent 5.43% of its operating revenues towards interest expenses and 5.97% towards employee costs in the year ending March 31, 2025.
Despite the challenging financial results, Chemplast Sanmar's stock price has demonstrated strong momentum with a 16.03% gain over the past week and 28.09% growth over the past month, significantly outperforming the broader market. The stock has demonstrated resilience with 18.01% gains over the past week compared to the Sensex's 0.64% increase, and 27.63% growth in the last month versus the Sensex's 0.83%. However, the company faces significant financial challenges including a high debt burden with a debt-equity ratio of 0.54 and negative return on equity of -5.34%. The company's market capitalization stands at ₹4,902.98 crore with 15.81 crore shares outstanding as of December 31, 2025. Recent technical indicators suggest mixed signals with both bullish and bearish signals across different timeframes, while analysts have provided a median target price of ₹356.33 with a high estimate of ₹460.0 and low estimate of ₹265.0 for the next 12 months.
